Journal
NATURE BIOTECHNOLOGY
Volume 19, Issue 6, Pages 553-558Publisher
NATURE AMERICA INC
DOI: 10.1038/89305
Keywords
-
Categories
Funding
- NIGMS NIH HHS [GM58867-01] Funding Source: Medline
Ask authors/readers for more resources
Changes in glycosylation are often associated with disease progression, but the genetic and metabolic basis of these events is rarely understood in detail at a molecular level. We describe a metabolism-based approach to the selection of mutants in glycoconjugate biosynthesis that provides insight into regulatory mechanisms for oligosaccharide expression and metabolic flux. Unnatural intermediates are used to challenge a specific pathway, and cell surface expression of their metabolic products provides a readout of flux in that pathway and a basis for selecting genetic mutants. The approach was applied to the sialic acid metabolic pathway in human cells, yielding novel mutants with phenotypes related to the inborn metabolic defect sialuria and metastatic tumor cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available